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1. Introduction 
For many years it has been recognised that not all 
the properties of pyrazole are due to the molecule 
itself [l-4]. With the elucidation of the metabolism 
of pyrazole [S] it was appreciated that several metab- 
olites could possess biological activity. In {6] an in 
vitro inhibition of catalase (EC 1 .l 1 .1.6) by 4-hy- 
droxypyrazole (4-HP), one of the major metabolites 
of pyrazole was reported. This paper confirms the 
inhibition of catalase by 4-HP but also describes the 
importance of incubation time, a factor not studied 
earlier. We also describe the effects of 4-HP admini- 
stration to mice on liver catalase activity. 
2. Materials and methods 
4-Hydroxypyrazole was kindly supplied by Eli 
Lilly Research Labs. (Indianapolis, IN). Catalase 
(suspension from beef liver, Boehringer, Mannheim) 
was diluted with 0.05 M phosphate buffer (JrH 7.0). 
Catalase activity was followed spectrophotometric~y, 
measuring the decrease in AZ40 for 1 min after addi- 
tion of substrate (HsOs, final cont. 10 mM) [7]. Pre- 
incubation times were calculated from addition of 
the enzyme to the cuvette containing 4-HP but not 
substrate. 
In vivo inhibition was studied by injecting 4-HP 
(I mmol/kg, i-p.) into male mice (25-35 g, NMRI/ 
BOM strain). At set times after injection, the mice 
were decapitated, the liver quickly excised, rinsed in 
ice-cold phosphate buffer, weighed and homogenised 
* To whom correspondence should be addressed 
ElsevierlNorth-Holland Biomedical Press 
using a Potter-Elvehjem homogeniser with a Teflon 
pestle. The crude homogenate was further diluted 
before measurement sothat 1 g liver was diluted to 
250 ml. Of this solution 17 ti was used for measure.. 
ment, diluted with 650 ~1 phosphate buffer and 333 
~1 HzOz (30 mM). Activity was assayed as described, 
each sample being determined in duplicate. Between 
the death of the animal and the measurement of the 
duplicate sample <5 min elapsed. 
3. Results 
We obtained adose-dependent i hibition of catalase 
activity with 4-W in vitro as in f6]. However, the 
extent of the inhibition was dependent, not only on 
the concentration of 4.HP, but also on the time of 
pre-incubation before assay. From plots of inhibition 
against time, it was possible to calculate the time 
required for various concentrations of 4-HP to inhibit 
catalase by 50%. There was a clear relationship 
between time and concentration (table 1). After 
storage for 96 h, 1 &M was sufficient o inhibit enzyme 
activity by 50% compared to a similarly stored con- 
Table 1 
The concentration of 4”hydroxypyrazole required to inhibit 
catalase activity by 50% at various times 
Time (h) 1 2 3 4 24 48 12 96 
4-HP &M) 150 83 60 34 24 17 8 1 
For the first 4 h the tubes were stored at 22OC and thereafter 
at 4°C. The concentrations causing 50% ~ibition were 
obtained by plotting log [4-HP] against % inhibition. During 
the course of the experiment, control activity declined from 
156-124 units/mm 
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trol sampie. This was 150-times less 4-HP than was 
needed to inhibit the enzyme to a similar degree after 
only 1 h incubation. 
Exogenous Hz02 in the pre-incubation mixture 
did not accelerate the rate of inhibition. Once the 
~~b~t~on f enzyme activity was complete increasing 
the substrate concentration was ineffectual in restoring 
activity. The irreversible nature of the inhibition was 
confirmed by the failure of both gel filtration (table 2) 
and overnight dialysis to prevent the inhibitory effects 
of 4-HP. 
Injection of 4-HP (1 mmoI~kg) into mice resulted 
in a rapid and almost complete block of liver catalase 
activity (fig.1). One hour after injection, the activity 
was negligible. There was a gradual recovery with 
time, but even 2 days after injection, liver catalase 
activity was still only 75% of control. In a separate 
4c 
30 
20 
IO 
Table 2 
The effect of gel filtration on the inhibition of catatase 
activity by 4-hydroxypyrazole 
Time 
(min) 
Treatment Activity (M/mm) 
Control 4-HP 
% of 
control 
0 
10 
30 
60 
no filtration 69 69 100 
after filtration 51 55 97 
no filtration 69 23 33 
after filtration 58 15 26 
no filtration 61 5 8 
after filtration 53 3 6 
no fdtration 67 0 0 
after fdtration 50 0 0 
Catalase was incubated with 4-HP (at 200 MM in the pre- 
incubation mixture) and at the times stated a sample from 
the incubation mixture was subjected to gel filtration by 
passage through a Sephadex G-25 column, a procedure which 
completely separated free 4-HP from that bound to the 
enzyme. Control samples did not contain 4-HP but were 
otherwise identical 
TIME IIY HOURS 
Fig.1. Effect of a single injection of 4-hydroxypyrazole (1 mmoljkg) on the activity of mouse liver catalase. Results are means 2 
SEM from groups of 5 mice with the exception of the 1.5 min group (n = 3). Control mice (n = 15) were killed at various times 
throughout the experiment but are pooled for the purpose of presentation. AU values differ significantly from controls (P 
<O.Ol). 
62 
Volume 120, number 1 FEBS LETTERS October 1980 
experiment, acomparison was made between the in 
vivo and in vitro inhibitory properties of 4-HP. One 
hour after injection of 4-HP (1 mmol/kg), the activity 
in mouse liver was inhibited by 90%. It can be calcu- 
lated that the [6HP] in the assay system was 
between 68 nM (assuming equal distribution through- 
out the body) and 1.36 I.~M (assuming complete con- 
centration of 4-HP in liver). In contrast, to obtain an 
equivalent i~ibition of mouse liver catalase activity 
after 1 h of in vitro incubation, 4-HP at 133 I.CM was 
necessary. 
4. Discussion 
In the study on the inhibitory properties of 4-HP, 
]6] the effect of incubation time was not considered. 
They calculated that 4-HP at 3.38 mM was the con- 
centration producing 50% inhibition. However, as we 
have shown, the time of incubation is as important a 
factor as concentration i  determining the degree of 
inhibition and micromolar concentrations of 4-HP 
will cause total inhibition given sufficient ime. 
Although we have not performed etailed analysis 
of kinetics of the inhibition, it is clear that the inhibi- 
tion is irreversible being reversed neither by gel fdtra- 
tion nor overnight dialysis. Evidence of its irreversible 
nature was also obtained in vivo, as recovery from a 
single injection of 4-HP seemed to depend on resyn- 
thesis of new enzyme [8]. The recovery was very 
similar to that seen after administration of pyrazole 
[2], the significant difference in the time course being 
the slow onset of the blockade with pyrazole, maxi- 
mum ~hibition occurring -24 h after adm~istration. 
M~mum i~bition with 4HP occurred almost 
immediately after injection. 
There are several explanations for the differences 
in [4HP] inhibiting mouse liver catalase in vitro and 
in vivo. Nearly all liver catalase islocated in micro- 
bodies termed peroxisomes [9] and there is evidence 
that drugs can penetrate their membranes [lo]. If 
4.HP is rapidly taken up by peroxisomes, which we 
cannot exclude, then the local [4-HP] inside the 
peroxisomes and in contact with the catalase may be 
considerably greater than that which we have esti- 
mated, even assuming [4-HP] in the liver as a whole. 
However, other explanations are possible. Metabolites 
of 4HP have been identified [S] and it is possible 
that these may be even more potent inhibitors of 
catalase. 4HP may have other effects either directly 
on the liver or indirectly, through the accumulation 
of toxic peroxide metabolites normally metabolised 
by catalase. 
4-HP is a very potent i~bitor of catalase, 50% 
i~ibition is obtained at PM levels, whereas most syn- 
thetic catalase inhibitors act at mM levels. It seems 
likely that 4-HP is not only responsible for the inhibi- 
tion in vivo of catalase by pyrazole, but for many of 
its other toxic effects. This explains why 4-methyl- 
pyrazole, which cannot be metabolised to 4-HP, is 
much less toxic than pyrazole [ 111. 
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